zones 1 4 . There is suggestive evidence that HAM may be autoimmune in nature. The findings of high levels of antibodies against HTLV-1 and oligoclonal IgG bands in CSF and serum is, perivascular cuffing by lymphocytes observed in autopsy 1 , and improvement of the clinical state with steroids and danazol .15 favor a role for autoimmunity in the pathogenesis of HAM. Several papers have described that HAM may be associated with other non-neurologic diseases as ichthyosis, uveits, arthropathy, polymiosytis, vasculitis, Sjogren's syndrome, alveolitis and adult T-cell leukemia/lymphoma is. These pleomorphic manifestations and the findings that less than 1% of seropositives subjects will manifest clinical disease, points to an immunological systemic disease whose clinical express is related to the immunogenetic relationship between the organism and the virus.
In Brazil, positive serology for HTLV-1 was observed in AIDS risk groups 5, among natives in the Amazon region 1 2 and among adult patients with T-cell leukemias or lymphomas is. The first cases of myelopathy associated with positive serology for HTLV-1 in Brazil were detected in São Paulo and later in Fortaleza and Salvador 4-6; positive CSF was observed by Spina-França and colleagues in 24 of 56 cases of spastic myelopathies 22.
Out of two papers 2 »2iy all the information regarding the association between HTLV-1 and myelopathy are descriptive being necessary analytical studies whose features are more appropriate to establish associations. It is our proposal to establish the risk of infections due to HTLV-1 in patients with myelopathy in Salvador.
PATIENTS AND METHOD'S
The study was carried out in Salvador, the capital city of the State of Bahia, located in the Northeastern region of Brazil, at 12 degrees 59 minutes South latitude and 38 degrees 31 minutes West longitude. The city's population is predominantly mulatto due to miscegenation. The study was based on 28 cases of myelopathy out of 49 which were diagnosed between June 1990 and December 1991. Both the study and the control groups were chosen using the blind selection method and were matched 1:1. The matching criteria were age (margin of ± 3 years) and sex. All the patients were from the same hospital, a philantropic institution exclusively for lower income individuals. All participants in both the study and control groups underwent serology tests for HTLV-1 and HIV. The cases of myelopathy with positive results also underwent CSF tests for anti-HTLV-1 antibodies.
The CSF from all participants was tested for cells, proteins, protein electrophoresis and infectious or parasitic diseases (syphilis, toxoplasmosis, cysticercosis, and schistosomosis). These exams were carried out in a single laboratory by the same researcher using identical techniques. All participants also underwent either magnetic resonance of the spinal cord or myelography. Serum and CSF exam for HTLV-1: antibodies to HTLV-1 were detected with a commer cially available enzyme immunoassay (EIA). EIA repeatedly reactive samples were further examined using a new dot blot confirmatory immunoassay with highly purified HTLV-1 viral and recombinant proteins as an antigen source. Samples were considered positive if antibo dies against both the gag (p24) and env (p21E) gene products were present.
The odds ratio (OR) was calculated for analysis of case-control studies matched 1:1 and the respective 95% confidence intervals. A statistical significancy test was carried out using the McNemar chi-square test for studies matched 1:1. The mean age was compared by t-student.
RESULTS
Of the 28 pairs, 14 were male and 14 were female; 17 of the study group and 17 from the control group (60.7%) have always resided in the State capital; the others are from other parts of the State and currently reside in Salvador. The patients were predominantly mulatto. The participants from both the study and control groups were blue collar workers (construction workers, masons, farm workers, maids, etc.) in the study group there were three people from a high risk group for AIDS (one homosexual, one prostitute and one who had received a blood transfusion in the past).
Study and control groups had mean ages of respectively 44.6 ± 15.6 years and 43.5 ± 16 years, p>0.05 (Table 1) .
Of the 28 study cases, 12 (42.8%) had positive serology and CSF for HTLV-1 and 4 controls (14.3%) had positive serologies. Their pairs, according to their test results, appear in Table 2 , with an estimated relative risk (odds ratio, OR) of 9.0, p<^0.02.
No patient showed suggestive images of spinal cord compression using MRI or myelo graphy. All patients had a CSF cellularity from 1 to 40, with a predominance of lymphocytes. In 100% of the patients the total proteins were above 40mg% and gamaglobulin in the CSF was above 14%. No patient showed positive tests for infectious or parasitic diseases; none were HIV positive.
COMMENTS
Despite the fact that there were 49 patients with myelopathy who fulfilled the methodological study criteria, it was possible to find only one adequate pair for 28 among those who fulfilled the criteria for the control group and who had already undergone serology tests for HTLV-1. As patients with myelopathy Since this is the third analytical study on the association between HTLV-1 and myelopathy available to the scientific community, this model should be encouraged and more detailed case studies should be carried out, thus allowing greater control of the confounding, variables.
